Vote: Floor vote
NY SenateMar 24, 2026Result: passed
Sponsor · State Senator, District 20 · Democratic
Senate bill · S438 (2025-26)
Establishes the prescription drug supply chain transparency act; requires pharmacy services administrative organizations, pharmacy switch companies and rebate aggregators to register with the insurance department and to provide certain disclosures relating to the ownership and activities of such entities; relates to deposits into the pharmacy benefit manager regulatory fund.
Not chosen yet
Passed one of the two chambers; it still needs the other.
New York State Senate
Amends the Insurance Law.
Insurance · New York State Assembly
Also referred to Insurance · New York State Senate.
Requires registration and disclosures by Pharmacy Services Administra- tive Organizations (PSA0s), switch companies, and rebate aggregators to the Department of Financial Services (DFS). SUMMARY: Section 1 names the act the "Prescription Drug Supply Chain Transparency Act." Section 2 adds Article 30 to the Insurance Law (sections 3001-3010), defining manufacturer, PSAO, rebate aggregator, and switch company; requires electronic filings, special reports, investigations by the DFS Superintendent, registration, and disclosures; and directs fees and penalties to the Pharmacy Benefit Manager Regulatory Fund under State Finance Law section 99-oo. Section 3 amends State Finance Law section 99-oo to deposit collected fees and penalties into the fund. Section 4 sets the effective date.
Filed with the bill. Read it on nysenate.gov (opens in a new tab)
NY SenateMar 24, 2026Result: passed
NY SenateFeb 24, 2026Result: passed
Senate InsuranceFeb 9, 2026Result: passed
NY SenateFeb 25, 2025Result: passed
Senate InsuranceFeb 3, 2025Result: passed
The sponsor's argument
Rising drug costs burden New Yorkers. Intermediaries such as PBMs, PSAOs, switch companies, and rebate aggregators operate with little oversight and may engage in conflicts of interest, anticompetitive, or deceptive practices that raise costs. Federal scrutiny has increased, including a 2022 FTC inquiry and a 2023 U.S. House investigation. The bill increases transparency and accountability through annual registra- tion, conflict disclosures, and audited financial reporting.
This is the sponsor's own case for the bill, quoted from their memorandum. It is not Agora's description of what the bill does.
Referred to committee
REFERRED TO INSURANCE
NY Assembly
Passed a chamber
REPASSED SENATE
NY Senate
Returned to Assembly
RETURNED TO ASSEMBLY
NY Senate
Amended
AMENDED ON THIRD READING 438A
NY Senate
Recalled From Assembly
RECALLED FROM ASSEMBLY
NY Senate
Returned to Senate
RETURNED TO SENATE
NY Assembly
Sent to the executive
DELIVERED TO ASSEMBLY
NY Senate
Passed a chamber
PASSED SENATE
NY Senate
Referred to committee
REFERRED TO INSURANCE
NY Assembly
Advanced to Third Reading
ADVANCED TO THIRD READING
NY Senate
2ND Report CAL.
2ND REPORT CAL.
NY Senate
1ST Report CAL.296
1ST REPORT CAL.296
NY Senate
Died in Assembly
DIED IN ASSEMBLY
NY Assembly
Referred to committee
REFERRED TO INSURANCE
NY Senate
Sent to the executive
DELIVERED TO ASSEMBLY
NY Senate
Passed a chamber
PASSED SENATE
NY Senate
Referred to committee
REFERRED TO INSURANCE
NY Assembly
Advanced to Third Reading
ADVANCED TO THIRD READING
NY Senate
2ND Report CAL.
2ND REPORT CAL.
NY Senate
1ST Report CAL.232
1ST REPORT CAL.232
NY Senate
Referred to committee
REFERRED TO INSURANCE
NY Senate
The summary comes from NY Open Legislation, the New York State Senate's public record. For more, see How we handle summaries.
The list shows the cosponsors who are on Agora, A to Z. The official record may list more.
Parties are shown in the same neutral colors.
From NY Open Legislation, the NY Senate and Assembly, and official rosters. This record was last updated Oct 29, 2026. About our data